EE04550B1 - Dibensotiasepiini kristalliline derivaat, selle saamise protsess, selle kasutamine ravimitootmiseks ja seda sisaldav farmatseutiline kompositsioon - Google Patents

Dibensotiasepiini kristalliline derivaat, selle saamise protsess, selle kasutamine ravimitootmiseks ja seda sisaldav farmatseutiline kompositsioon

Info

Publication number
EE04550B1
EE04550B1 EEP200000062A EEP200000062A EE04550B1 EE 04550 B1 EE04550 B1 EE 04550B1 EE P200000062 A EEP200000062 A EE P200000062A EE P200000062 A EEP200000062 A EE P200000062A EE 04550 B1 EE04550 B1 EE 04550B1
Authority
EE
Estonia
Prior art keywords
crystalline
medicament
manufacture
preparation
pharmaceutical composition
Prior art date
Application number
EEP200000062A
Other languages
English (en)
Estonian (et)
Inventor
William Snape Evan
Original Assignee
Zeneca Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Limited filed Critical Zeneca Limited
Publication of EE200000062A publication Critical patent/EE200000062A/xx
Publication of EE04550B1 publication Critical patent/EE04550B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Liquid Crystal Substances (AREA)
EEP200000062A 1997-08-01 1998-07-28 Dibensotiasepiini kristalliline derivaat, selle saamise protsess, selle kasutamine ravimitootmiseks ja seda sisaldav farmatseutiline kompositsioon EE04550B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9716161.6A GB9716161D0 (en) 1997-08-01 1997-08-01 Process
PCT/GB1998/002260 WO1999006381A1 (en) 1997-08-01 1998-07-28 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent

Publications (2)

Publication Number Publication Date
EE200000062A EE200000062A (et) 2000-10-16
EE04550B1 true EE04550B1 (et) 2005-10-17

Family

ID=10816746

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000062A EE04550B1 (et) 1997-08-01 1998-07-28 Dibensotiasepiini kristalliline derivaat, selle saamise protsess, selle kasutamine ravimitootmiseks ja seda sisaldav farmatseutiline kompositsioon

Country Status (32)

Country Link
US (2) US6372734B1 (xx)
EP (2) EP1000043B1 (xx)
JP (2) JP2001512109A (xx)
KR (1) KR20010022241A (xx)
CN (1) CN1125058C (xx)
AT (2) ATE496037T1 (xx)
AU (1) AU739255B2 (xx)
BG (1) BG64796B1 (xx)
BR (1) BR9811061A (xx)
CA (1) CA2295792C (xx)
CY (2) CY2200162T2 (xx)
CZ (1) CZ299225B6 (xx)
DE (4) DE69842104D1 (xx)
EE (1) EE04550B1 (xx)
ES (2) ES2296575T3 (xx)
GB (2) GB9716161D0 (xx)
HK (2) HK1029992A1 (xx)
HU (1) HU228620B1 (xx)
ID (1) ID24219A (xx)
IL (1) IL133618A (xx)
MY (1) MY120999A (xx)
NO (1) NO20000484L (xx)
NZ (1) NZ501914A (xx)
PL (1) PL338384A1 (xx)
PT (2) PT1589008E (xx)
RU (1) RU2224754C2 (xx)
SI (2) SI1589008T1 (xx)
SK (1) SK287145B6 (xx)
TR (1) TR200000848T2 (xx)
TW (1) TW533207B (xx)
WO (1) WO1999006381A1 (xx)
ZA (1) ZA986904B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2000141A1 (en) * 2002-03-20 2008-12-10 Teva Pharmaceutical Industries Ltd. Methods for preparing crystalline quetiapine hemifumarate
US7071331B2 (en) 2003-02-22 2006-07-04 Teva Pharmaceutical Industries Ltd. Synthesis of quetiapine and pharmaceutically acceptable salts thereof
US7238686B2 (en) * 2003-03-03 2007-07-03 Hetero Drugs Limited Polymorphs of quetiapine fumarate
EP1611138A1 (en) 2003-04-07 2006-01-04 Hetero Drugs Limited A novel crystalline form of dorzolamide hydrochloride
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
WO2006035293A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Polymorphic forms of quetiapine hemifumarate
WO2006056772A2 (en) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Salts of quetiapine
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
JP2008502707A (ja) 2005-04-14 2008-01-31 テバ ファーマシューティカル インダストリーズ リミティド クエチアピンフマレートの調製方法
US20070072840A1 (en) * 2005-05-30 2007-03-29 Pandya Bhargav Polymorphic forms of quetiapine
EP1928849A1 (en) 2005-09-30 2008-06-11 Fermion Oy New crystallization process of quetiapine hemifumarate
EP1948628A1 (en) * 2005-10-28 2008-07-30 Fermion Oy Quetiapine hemifumarate purification by crystallization
US8389510B2 (en) * 2005-11-18 2013-03-05 Astrazeneca Ab Crystalline forms
CN101360502B (zh) * 2005-11-18 2012-03-14 阿斯利康公司 结晶形式
US20090215744A1 (en) * 2005-11-18 2009-08-27 Astrazeneca Ab Solid Formulations
CN101360503A (zh) * 2005-11-18 2009-02-04 阿斯利康公司 液体制剂
JP2009516705A (ja) * 2005-11-18 2009-04-23 アストラゼネカ・アクチエボラーグ 塩の形態
CZ300451B6 (cs) * 2006-07-03 2009-05-20 Farmak, A. S. Zpusob prípravy solí 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanolu (quetiapinu) a jejich cištení
WO2008066620A2 (en) * 2006-10-20 2008-06-05 Concert Pharmaceuticals Inc. Dibenzothiazepine derivatives
ATE480227T1 (de) 2007-02-14 2010-09-15 Lesvi Laboratorios Sl Pharmazeutische zusammensetzungen mit quetiapinfumarat
EP2144892A2 (en) * 2007-03-29 2010-01-20 Teva Pharmaceutical Industries Ltd. Improved process for preparing quetiapine fumarate
WO2009004480A2 (en) * 2007-05-07 2009-01-08 Actavis Group Ptc Ehf Quetiapine salts and their polymorphs
US20090082334A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched quetiapine
EP2229364B1 (en) * 2007-12-05 2015-02-25 Janssen Pharmaceutica, N.V. Dibenzoazepine and dibenzooxazepine trpa1 agonists
SI2262486T1 (sl) 2008-08-01 2013-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Sestavek kvetiapina
US20100069356A1 (en) * 2008-09-17 2010-03-18 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
US20120071649A1 (en) 2009-03-04 2012-03-22 Ranbaxy Laboratories Limited Process for the preparation of quetiapine fumarate
WO2013024072A1 (en) 2011-08-12 2013-02-21 Qiagen Gmbh Method for isolating nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787249A (fr) 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound

Also Published As

Publication number Publication date
AU8549898A (en) 1999-02-22
ZA986904B (en) 1999-02-01
EP1589008B1 (en) 2011-01-19
TR200000848T2 (tr) 2000-08-21
HU228620B1 (en) 2013-04-29
ES2296575T1 (es) 2008-05-01
EE200000062A (et) 2000-10-16
SK287145B6 (sk) 2010-01-07
SI1000043T1 (sl) 2010-01-29
JP2001512109A (ja) 2001-08-21
BG64796B1 (bg) 2006-04-28
DE69841216D1 (de) 2009-11-19
NO20000484L (no) 2000-03-16
GB9814882D0 (en) 1998-09-09
CZ2000341A3 (cs) 2000-05-17
AU739255B2 (en) 2001-10-04
ID24219A (id) 2000-07-13
CN1125058C (zh) 2003-10-22
CA2295792A1 (en) 1999-02-11
BR9811061A (pt) 2000-09-19
TW533207B (en) 2003-05-21
DE98936529T1 (de) 2008-11-20
DE69842104D1 (de) 2011-03-03
EP1000043A1 (en) 2000-05-17
HUP0002663A3 (en) 2001-10-29
JP2009102345A (ja) 2009-05-14
IL133618A (en) 2004-02-08
IL133618A0 (en) 2001-04-30
EP1589008A1 (en) 2005-10-26
ES2296575T3 (es) 2010-02-05
ATE444959T1 (de) 2009-10-15
US6372734B1 (en) 2002-04-16
KR20010022241A (ko) 2001-03-15
CY2200162T2 (el) 2010-07-28
ES2296568T3 (es) 2011-05-06
CY2200161T2 (el) 2010-07-28
HK1029992A1 (en) 2001-04-20
ES2296568T1 (es) 2008-05-01
SK1302000A3 (en) 2000-06-12
PT1000043E (pt) 2009-11-30
PL338384A1 (en) 2000-10-23
CZ299225B6 (cs) 2008-05-21
NZ501914A (en) 2001-09-28
RU2224754C2 (ru) 2004-02-27
HUP0002663A2 (hu) 2001-09-28
CN1265101A (zh) 2000-08-30
HK1081962A1 (en) 2006-05-26
ATE496037T1 (de) 2011-02-15
EP1000043B1 (en) 2009-10-07
DE05011169T1 (de) 2008-11-06
NO20000484D0 (no) 2000-01-31
CA2295792C (en) 2007-04-17
GB9716161D0 (en) 1997-10-08
WO1999006381A1 (en) 1999-02-11
US20020147186A1 (en) 2002-10-10
MY120999A (en) 2005-12-30
BG104176A (en) 2000-08-31
SI1589008T1 (sl) 2011-04-29
PT1589008E (pt) 2011-03-23

Similar Documents

Publication Publication Date Title
EE04550B1 (et) Dibensotiasepiini kristalliline derivaat, selle saamise protsess, selle kasutamine ravimitootmiseks ja seda sisaldav farmatseutiline kompositsioon
AU560179B2 (en) Hypoglycemic thiazolidinedione derivatives
HUP9802578A3 (en) Phenylacetic acid derivatives, process and intermediates for producing them, fingicide, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients and use thereof
EE200100318A (et) Kinoliini derivaat, selle ühendi kasutamine ravimina, seda sisaldav farmatseutiline kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
ATE136905T1 (de) Dermorphin-analoge, deren herstellungsverfahren, pharmazeutische zusammensetzungen und methode zur therapeutischen behandlung unter verwendung der analoge
HUP9701694A3 (en) Indolinone derivatives for the treatment of disease, use thereof, pharmaceutical compositions containing these compounds
UA66852C2 (uk) Похідні та аналоги 3-арилпропіонової кислоти, спосіб їх отримання, фармацевтична композиція (варіанти) та спосіб профілактики та/або лікування асоційованих з резистентністю до інсуліну клінічних станів
CA2272705A1 (en) Fused bicyclic pyrimidine derivatives
UA41446C2 (uk) Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі
IL114894A (en) Pyrrolidine derivatives as endothelin antagonists, pharmaceutical compositions containing them, and their use in the preparation of medicaments
YU242789A (en) New compound, 4-fluoro-2-//(4-metoxy-2-pyridin-yl)methylsulphinyl/-1h-benzimidazole and process for obtaining
HUP9900320A3 (en) Optically active thiazolidinone derivatives, preparation thereof, pharmageutical compositions containing these compounds as active ingredients and use of thia-or oxazolidine derivatives for preparation of pharmaceutical compositions
DE69300453T2 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
HUP0200785A3 (en) Thiazolidinedione derivative and its use as antidiabetic, process for its preparation and pharmaceutical composition containing it
DE69411387T2 (de) Verfahren zur Herstellung von pharmazeutisch aktiven Benzothiazepinderivaten.
ATE190628T1 (de) Zusammensetzungen von wachstumsfaktoren, herstellung und verwendung
AU2090900A (en) Novel gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.
ZA923502B (en) 1-amidoocthydropyrido[2,1-c][1,4]oxazine compounds, processes for preparing these and pharmaceutical compositions containing them
YU125289A (en) Process for preparing pharmaceutic compounds with delayed effect of healing substance, for oral use, which contains new inclusion complex of nicardipine, or it's hydrochloride with beta-cyclodextrine

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20160728